Therefore, identification of Baicalein could be a potent DNMT1 inhibitor to repress JAK2/STAT5 survival pathway in CML CD34+ cells. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.